| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA1160420
Max Phase: Preclinical
Molecular Formula: C15H26N4O6
Molecular Weight: 358.40
Molecule Type: Protein
Associated Items:
Representations
Canonical SMILES: CC(=O)NCCCC[C@H](NC(C)=O)C(=O)NCC(=O)N[C@H](C)C(=O)O
Standard InChI: InChI=1S/C15H26N4O6/c1-9(15(24)25)18-13(22)8-17-14(23)12(19-11(3)21)6-4-5-7-16-10(2)20/h9,12H,4-8H2,1-3H3,(H,16,20)(H,17,23)(H,18,22)(H,19,21)(H,24,25)/t9-,12+/m1/s1
Standard InChI Key: CSYBFMSGKJDWEG-SKDRFNHKSA-N
Associated Targets(non-human)
Beta-lactamase 730 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 358.40 | Molecular Weight (Monoisotopic): 358.1852 | AlogP: -1.50 | #Rotatable Bonds: 11 |
| Polar Surface Area: 153.70 | Molecular Species: ACID | HBA: 5 | HBD: 5 |
| #RO5 Violations: 0 | HBA (Lipinski): 10 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 3.66 | CX Basic pKa: | CX LogP: -2.71 | CX LogD: -6.04 |
| Aromatic Rings: 0 | Heavy Atoms: 25 | QED Weighted: 0.28 | Np Likeness Score: -0.37 |
References
| 1. Xu Y, Pratt R. (1994) -lactam-recognizing enzymes exhibit different structural specificity in acyclic amide and ester substrates: a starting point in -lactamase evolution?, 4 (19): [10.1016/0960-894X(94)85027-5] |
Source
Source(1):